Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HOOKIPA Pharma Inc. - Common Stock (NQ:HOOK)

0.8403 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HOOKIPA Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Earnings Outlook For HOOKIPA Pharma
 
Via Benzinga
HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Looking Into HOOKIPA Pharma's Return On Capital Employed
 
Via Benzinga
HOOKIPA Pharma's Earnings Outlook
 
Via Benzinga
Looking Into HOOKIPA Pharma's Return On Capital Employed
 
Via Benzinga
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 11, 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
HOOKIPA Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 15, 2023
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA to Present at the SVB Securities Global Biopharma Conference
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
HOOKIPA Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA to Participate in The JMP Securities Hematology and Oncology Summit
From HOOKIPA Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Why Advance Auto Parts Shares Are Trading Lower By Around 13%; Here Are 18 Stocks Moving Premarket
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares rose 55.1% to $0.1578 in pre-market trading after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Sidoti's November Micro-Cap Virtual Conference
Via ACCESSWIRE
HOOKIPA Pharma to Report Third Quarter 2022 Financial Results and Corporate Updates on November 14, 2022
From HOOKIPA Pharma Inc.
Via GlobeNewswire
HOOKIPA to Participate in the Sidoti Micro-Cap Virtual Conference
From HOOKIPA Pharma Inc.
Via GlobeNewswire
10 Best Medical Stocks Under $5
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.